These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7680193)

  • 1. Classification of lymphoproliferative disorder of granular lymphocytes.
    Wong KF; Chan JK
    Arch Pathol Lab Med; 1993 Mar; 117(3):233-4. PubMed ID: 7680193
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoproliferative disorder of granular lymphocytes. More questions than answers.
    McKenna RW
    Arch Pathol Lab Med; 1992 Mar; 116(3):235-7. PubMed ID: 1371378
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
    McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
    Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
    Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
    Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the major phenotype of large granular T-cell lymphoproliferative disorder.
    Sun T; Brody J; Koduru P; Vinciguerra V; Weiselberg L; Marino J; Chaudhri F; Papps J; Erickson R
    Am J Clin Pathol; 1992 Nov; 98(5):516-21. PubMed ID: 1283056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple pulmonary nodules manifested in a patient with NK cell granular lymphocyte proliferative disorder.
    Furuno T; Hara N; Hagimoto N; Mori N; Muranishi H
    Chest; 1994 Jun; 105(6):1893-5. PubMed ID: 7515779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polyclonal and clonal proliferation of large granular lymphocytes].
    Kowal M; Dmoszyńska A
    Pol Arch Med Wewn; 1995 Oct; 94(4):349-57. PubMed ID: 8834130
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the platelet-type thrombin receptor in 20 cases of large granular lymphocyte proliferations.
    Macey MG; Howells GL; Stone SR; Newland AC
    Leukemia; 1996 Apr; 10(4):687-92. PubMed ID: 8618448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential accumulation of mature NK cells during human immunosenescence.
    Krishnaraj R; Svanborg A
    J Cell Biochem; 1992 Dec; 50(4):386-91. PubMed ID: 1281821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural killer cells of different immunological phenotypes (CD16+, CD56+ and CD57+) in the blood of patients with insulin-dependent diabetes mellitus].
    Shliakhovenko VS; Guzov MA; Milenko SE; Mikhaĭlovskaia EV; Kalinovskiĭ AK; Khodak AA; Zak KP
    Vrach Delo; 1991 Feb; (2):36-9. PubMed ID: 1711735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine markers expressed by human natural killer (NK) cells are also detectable on human small cell carcinomas, neuroblastomas, and sea urchin coelomocytes.
    Koros AM
    Int J Neurosci; 1990 Apr; 51(3-4):255-6. PubMed ID: 1703997
    [No Abstract]   [Full Text] [Related]  

  • 15. NCAM (CD56)-positive malignant lymphoma.
    Wong KF; Chan JK; Ng CS
    Blood; 1992 Nov; 80(9):2431-2. PubMed ID: 1384803
    [No Abstract]   [Full Text] [Related]  

  • 16. CD57+ cells and recurrent spontaneous abortion.
    Winger EE
    Am J Reprod Immunol; 2007 Oct; 58(4):311-4. PubMed ID: 17845200
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid method for purification of CD56+ natural killer cells with preferential enrichment of the CD56bright+ subset.
    Handgretinger R; Welte B; Dopfer R; Niethammer D
    J Clin Lab Anal; 1994; 8(6):443-6. PubMed ID: 7532707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
    Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
    Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disease of granular lymphocytes.
    Kugelman LC; Smith BR; Buckley P; Katz ME; Edelson RL
    J Am Acad Dermatol; 1995 May; 32(5 Pt 2):829-33. PubMed ID: 7722038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell subsets and alloresponsiveness in renal allograft recipients.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.